These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 20345906)

  • 1. Tetracysteine-tagged prion protein allows discrimination between the native and converted forms.
    Gaspersic J; Hafner-Bratkovic I; Stephan M; Veranic P; Bencina M; Vorberg I; Jerala R
    FEBS J; 2010 May; 277(9):2038-50. PubMed ID: 20345906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational detection of prion protein with biarsenical labeling and FlAsH fluorescence.
    Coleman BM; Nisbet RM; Han S; Cappai R; Hatters DM; Hill AF
    Biochem Biophys Res Commun; 2009 Mar; 380(3):564-8. PubMed ID: 19285001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prion protein NMR structure from tammar wallaby (Macropus eugenii) shows that the beta2-alpha2 loop is modulated by long-range sequence effects.
    Christen B; Hornemann S; Damberger FF; Wüthrich K
    J Mol Biol; 2009 Jun; 389(5):833-45. PubMed ID: 19393664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extremely rapid folding of the C-terminal domain of the prion protein without kinetic intermediates.
    Wildegger G; Liemann S; Glockshuber R
    Nat Struct Biol; 1999 Jun; 6(6):550-3. PubMed ID: 10360358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does tetracycline bind helix 2 of prion? An integrated spectroscopical and computational study of the interaction between the antibiotic and alpha helix 2 human prion protein fragments.
    Ronga L; Langella E; Palladino P; Marasco D; Tizzano B; Saviano M; Pedone C; Improta R; Ruvo M
    Proteins; 2007 Feb; 66(3):707-15. PubMed ID: 17152078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein.
    Leliveld SR; Stitz L; Korth C
    Biochemistry; 2008 Jun; 47(23):6267-78. PubMed ID: 18473442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of a spontaneously aggregating amyloid-forming variant of human PrP((90-231)) through phage-display screening of variants randomized between residues 101 and 112.
    Verma A; Sharma S; Ganguly NK; Majumdar S; Guptasarma P; Luthra-Guptasarma M
    Int J Biochem Cell Biol; 2008; 40(4):663-76. PubMed ID: 18023239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing misfolding of the prion protein by trimethylamine N-oxide.
    Bennion BJ; DeMarco ML; Daggett V
    Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptides and proteins in neurodegenerative disease: helix propensity of a polypeptide containing helix 1 of the mouse prion protein studied by NMR and CD spectroscopy.
    Liu A; Riek R; Zahn R; Hornemann S; Glockshuber R; Wüthrich K
    Biopolymers; 1999; 51(2):145-52. PubMed ID: 10397798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electron paramagnetic resonance evidence for binding of Cu(2+) to the C-terminal domain of the murine prion protein.
    Cereghetti GM; Schweiger A; Glockshuber R; Van Doorslaer S
    Biophys J; 2001 Jul; 81(1):516-25. PubMed ID: 11423433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleic acid and prion protein interaction produces spherical amyloids which can function in vivo as coats of spongiform encephalopathy agent.
    Nandi PK; Nicole JC
    J Mol Biol; 2004 Nov; 344(3):827-37. PubMed ID: 15533448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Full-length prion protein aggregates to amyloid fibrils and spherical particles by distinct pathways.
    El Moustaine D; Perrier V; Smeller L; Lange R; Torrent J
    FEBS J; 2008 May; 275(9):2021-31. PubMed ID: 18355314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Core structure of amyloid fibrils formed by residues 106-126 of the human prion protein.
    Walsh P; Simonetti K; Sharpe S
    Structure; 2009 Mar; 17(3):417-26. PubMed ID: 19278656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular model of an alpha-helical prion protein dimer and its monomeric subunits as derived from chemical cross-linking and molecular modeling calculations.
    Kaimann T; Metzger S; Kuhlmann K; Brandt B; Birkmann E; Höltje HD; Riesner D
    J Mol Biol; 2008 Feb; 376(2):582-96. PubMed ID: 18158160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences between the prion protein and its homolog Doppel: a partially structured state with implications for scrapie formation.
    Nicholson EM; Mo H; Prusiner SB; Cohen FE; Marqusee S
    J Mol Biol; 2002 Feb; 316(3):807-15. PubMed ID: 11866533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid formation by recombinant full-length prion proteins in phospholipid bicelle solutions.
    Lührs T; Zahn R; Wüthrich K
    J Mol Biol; 2006 Mar; 357(3):833-41. PubMed ID: 16466741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the 132-160 region in prion protein conformational transitions.
    Torrent J; Alvarez-Martinez MT; Liautard JP; Balny C; Lange R
    Protein Sci; 2005 Apr; 14(4):956-67. PubMed ID: 15772306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc).
    Bocharova OV; Breydo L; Parfenov AS; Salnikov VV; Baskakov IV
    J Mol Biol; 2005 Feb; 346(2):645-59. PubMed ID: 15670611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of recombinant prions with compounds of therapeutical significance.
    Georgieva D; Schwark D; von Bergen M; Redecke L; Genov N; Betzel C
    Biochem Biophys Res Commun; 2006 Jun; 344(2):463-70. PubMed ID: 16630566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atomic force microscopy to characterize the molecular size of prion protein.
    Kunze S; Lemke K; Metze J; Bloukas G; Kotta K; Panagiotidis CH; Sklaviadis T; Bodemer W
    J Microsc; 2008 May; 230(Pt 2):224-32. PubMed ID: 18445151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.